Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Beijing Gene+ Technology
company
About
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention
- 251 - 500
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $30M
- Industries
- Health Care,Life Science,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine.The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$58M
Beijing Gene+ Technology has raised a total of
$58M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2019 | Series B | $28M | 1 | — | — | Detail |
| Sep 14, 2016 | Series A | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Beijing Gene+ Technology is funded by 2 investors.
Desun Investments
and Huoshanshi Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Desun Investments
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
